Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanwaron C is a branded Kampo (traditional Japanese herbal) medicine developed and marketed by Sanwa Shoyaku. It is a tablet formulation of the traditional prescription Kakkon-ka-jutsu-bu-to (葛根加朮附湯), which is a water extract processed into an oral tablet form. The product is classified as a designated Class 2 over-the-counter (OTC) pharmaceutical in Japan. As a complex herbal formulation, it does not have a single molecular mechanism of action; instead, it relies on the synergistic effects of its constituent herbs, which typically include Pueraria Root, Atractylodes Lancea Rhizome, and Processed Aconite Root. It is primarily indicated for the relief of joint pain, neuralgia, and muscle aches, particularly in individuals with relatively low physical strength who suffer from cold extremities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanwaron C.